Abstract: A display device comprises pixels including a first sub-pixel, a second sub-pixel, a third sub-pixel, a fourth sub-pixel, and a fifth sub-pixel, each sub-pixel including an emission area, wherein the first sub-pixel and the fourth sub-pixel emit light of a first color, the second sub-pixel and the fifth sub-pixel emit light of a second color, the third sub-pixel emits light of a third color, a first emission area of the first sub-pixel, a second emission area of the second sub-pixel, a fourth emission area of the fourth sub-pixel, and a fifth emission area of the fifth sub-pixel surround a third emission area of the third sub-pixel, and the third emission area of the third sub-pixel has four interior angles equal to or greater than about 180 degrees, and another four interior angles equal to or less than about 90 degrees.

Abstract: An ingot growth apparatus according to an embodiment of the present invention comprises: a growth furnace having a main crucible which is disposed within the growth furnace and holds molten silicon therein in order to grow an ingot; a preliminary melting part having a preliminary crucible which is supplied with a solid silicon material, melts the solid silicon material, and supplies the molten silicon to the main crucible; a temperature detection sensor which is disposed above the preliminary melting part and detects the temperature of the solid silicon material or molten silicon held in the preliminary melting part; and a control part which controls supply of the molten silicon from the preliminary crucible to the main crucible on the basis of the temperature detected by the temperature detection sensor.

Abstract: The present disclosure relates to a heteroaryl derivative and uses thereof. The heteroaryl derivative of the present disclosure exhibits excellent inhibitory activity against EGFR and/or HER2, and thus may be usefully employed as a therapeutic agent for EGFR- and/or HER2-related diseases.

Abstract: An optical film for a display device, includes: a first refractive layer having an upper surface and a lower surface including first projections and second projections extending away from the lower surface in a first direction, the second projections having different heights than the first projections, the first projections having lateral sides with different angles of inclination that decrease in the first direction; and a second refractive layer disposed directly on the upper surface of the first refractive layer, the second refractive layer having a refractive index different from that of the first refractive layer.

Abstract: Disclosed is a method for controlling the supply of solid silicon to a preliminary crucible of an ingot growth apparatus for maintaining a constant amount of molten silicon in the preliminary crucible by measuring the height of the molten silicon in the preliminary crucible.

Abstract: Disclosed is a battery module, which includes: a battery cell assembly having at least one battery cell; a module case configured to accommodate the battery cell assembly; and at least one injection hole provided in a bottom portion of the module case to inject a thermally conductive adhesive into the module case.

Abstract: A manufacturing method of a semiconductor device may include: forming a stack comprising first material layers and second material layers that are alternately stacked; forming an opening in the stack; forming a first seed layer in the opening; forming a first buffer layer by surface-treating the first seed layer; and forming a blocking layer by oxidizing the first seed layer through the first buffer layer.

Abstract: Systems and methods for executing a vision inspector simulation for secondary battery production by one or more processors to perform operations. The operations include executing an apparatus operating unit comprising a 3D vision inspector and surface quality information of a material inspected by the 3D vision inspector, executing a defect checking unit and a detection adjustment unit for determining an operation of the 3D vision inspector, obtaining at least one of first user action information obtained through the apparatus operating unit, first user condition information obtained through the detection adjustment unit, or first model recipe setting information obtained through the quality checking unit, determining the operation of the 3D vision inspector based on at least one of the first user action information, the first user condition information, or the first model recipe setting information, and executing an operation of inspecting a surface of the material based on the operation.

Abstract: An electronic device package is disclosed. The electronic device package includes a board on which an electronic device is mounted, a molded portion formed to cover the electronic device on the board, and a conductive layer disposed on a surface of the molded portion and extended in a trench formed on the board.

Abstract: An electronic device package is disclosed. The electronic device package includes a board on which an electronic device is mounted, a molded portion formed to cover the electronic device on the board, and a conductive layer disposed on a surface of the molded portion and extended in a trench formed on the board.

Abstract: The present invention relates to an electrode heating device that dries an electrode. The electrode heating device comprises a heating body having a drying space through which the electrode passes, and a heating member that directly heats and dries a surface of the electrode that passes through the drying space to remove moisture from the electrode.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopy including baicalein as an active ingredient. Baicalein is capable of regulating thymic stromal lymphopoietin-mediated signal transduction. The pharmaceutical composition of the present invention can effectively suppress inflammatory responses of allergic or asthmatic diseases due to the presence of baicalein extracted from Scutellariae Radix that regulates TSLP-mediated intracellular signal transduction to inhibit intracellular phosphorylation of STATS and inhibit the binding of TSLP to TSLPR. In addition, the pharmaceutical composition of the present invention may further include one or more compounds having synergistic effects with baicalein. In this case, the pharmaceutical composition can more effectively suppress inflammatory responses of allergic diseases such as asthma or atopy.

Abstract: The present invention relates to a novel quinolinone derivative compound that regulates intracellular signal transduction mediated by TSLP and IL-33 to exhibit efficacy in preventing or treating allergic diseases such as asthma or atopic dermatitis. The quinolinone derivative compound of the present invention can effectively suppress inflammatory responses of allergic diseases such as asthma or atopic dermatitis. The present invention also relates to a pharmaceutical composition including the quinolinone derivative compound. The pharmaceutical composition of the present invention can be used to fundamentally prevent or treat various allergic and asthmatic diseases.

Abstract: The present disclosure relates to an electronic device. A memory controller stores a stream ID by changing the stream ID on the basis of the number of updates of data and the number of times garbage collection is performed. The memory controller controlling a memory device includes a flash transition layer generating a mapping relationship of first data received from a host on the basis of a first stream ID included in the first data, a stream ID controller receiving second data for updating the first data stored in the memory device on the basis of the mapping relationship generated based on the first stream ID, and determining a second stream ID to be assigned to the second data, and a request controller outputting a program command for storing the first data and third data including the second data and the second stream ID in the memory device.

Abstract: The present invention relates to anovel quinolinone derivative compound that regulates intracellular signal transduction mediated by TSLP and IL-33 to exhibit efficacy in preventing or treating allergic diseases such as asthma or atopic dermatitis. The quinolinone derivative compound of the present invention can effectively suppress inflammatory responses of allergic diseases such as asthma or atopic dermatitis. The present invention also relates to a pharmaceutical composition including the quinolinone derivative compound. The pharmaceutical composition of the present invention can be used to fundamentally prevent or treat various allergic and asthmatic diseases.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopy including baicalein as an active ingredient. Baicalein is capable of regulating thymic stromal lymphopoietin-mediated signal transduction. The pharmaceutical composition of the present invention can effectively suppress inflammatory responses of allergic or asthmatic diseases due to the presence of baicalein extracted from Scutellariae Radix that regulates TSLP-mediated intracellular signal transduction to inhibit intracellular phosphorylation of STATS and inhibit the binding of TSLP to TSLPR. In addition, the pharmaceutical composition of the present invention may further include one or more compounds having synergistic effects with baicalein. In this case, the pharmaceutical composition can more effectively suppress inflammatory responses of allergic diseases such as asthma or atopy.

Abstract: The present disclosure in some embodiments relates to an automatic configuration tool to configure and install a distributed antenna system and an installation guide using the same. According to an aspect of the present disclosure, a user or a designer is graphically provided with a user interface to define a shape of the distributed antenna system, and is provided with a configuration tool for generating a configuration file for a configuration of an actual distributed antenna system. According to another aspect of the present disclosure, there is suggested a distributed antenna system for providing an installation guide function by using a configuration file generated in the configuration tool.

Abstract: The present invention relates to an electrode heating device that dries an electrode. The electrode heating device comprises a heating body having a drying space through which the electrode passes, and a heating member that directly heats and dries a surface of the electrode that passes through the drying space to remove moisture from the electrode.

Abstract: The present invention relates to a peptide derivative for regulating the thymic stromal lymphoid protein-mediated signaling and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases and, more particularly, to a peptide derivative represented by Chemical Formula 1 and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases. According to the present invention, provided are a peptide derivative capable of effectively inhibiting the formation of an inflammatory response of allergy and asthma diseases and a pharmaceutical composition including the peptide derivative. By using the present invention, various allergy and asthma diseases can be fundamentally prevented or treated.

Abstract: The present invention relates to a peptide derivative for regulating the thymic stromal lymphoid protein-mediated signaling and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases and, more particularly, to a peptide derivative represented by Chemical Formula 1 and a pharmaceutical composition including the peptide derivative for preventing and treating allergy and asthma diseases. According to the present invention, provided are a peptide derivative capable of effectively inhibiting the formation of an inflammatory response of allergy and asthma diseases and a pharmaceutical composition including the peptide derivative. By using the present invention, various allergy and asthma diseases can be fundamentally prevented or treated.